Intra-arterial Chemotherapy for Children With Retinoblastoma
NCT00906113 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2016-10-04
Summary
Retinoblastoma is a cancer of the eye that occurs exclusively in children. The treatment for retinoblastoma may include surgery, chemotherapy, radiation and local treatments to the eye such as freezing (cryotherapy) and local radiation (brachytherapy). In some cases, a child with retinoblastoma will have active cancer in a single remaining eye with useful vision. In such cases, it is sometimes necessary to remove this eye. In such cases, the injection of chemotherapy directly into the artery that supplies the eye and the tumor may lead to regression of the tumor without the need to remove the eye.
This form of treatment was pioneered by a group in New York (Abramson et al). In this study the investigators will assess the efficacy and safety of the technique in a group of children with retinoblastoma.
Conditions
- Retinoblastoma
Interventions
- DRUG
-
Intra-arterial injection of melphalan
Injection of 5 milligrams of melphalan into the ophthalmic artery once every 3 weeks for a total of 6 courses
- DRUG
-
Injection of melphalan into the ophthalmic artery
Injection of 5 milligrams of melphalan into the ophthalmic artery in an eye affected by retinoblastoma
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Months
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Israel
Study Locations
More Related Trials
-
A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma
NCT04455139 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
NCT01466855 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
NCT00607984 ·Status: UNKNOWN ·Phase: NA
-
Topotecan Episcleral Plaque for Treatment of Retinoblastoma
NCT04156347 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors
NCT03245450 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topotecan Episcleral Plaque for Treatment of Retinoblastoma
NCT04428879 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
NCT06941272 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids
NCT04593745 ·Status: UNKNOWN ·Phase: NA
-
Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma
NCT03475121 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
NCT04037189 ·Status: UNKNOWN
-
Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma
NCT00889018 ·Status: UNKNOWN ·Phase: NA
-
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
NCT01329471 ·Status: UNKNOWN
-
The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
NCT02050243 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
NCT03611595 ·Status: RECRUITING ·Phase: PHASE1
-
CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma
NCT02319486 ·Status: COMPLETED ·Phase: PHASE4
-
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
NCT03015844 ·Status: AVAILABLE
-
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma
NCT02258815 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
NCT00334854 ·Status: UNKNOWN ·Phase: PHASE3
-
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
NCT02509234 ·Status: UNKNOWN
-
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435 ·Status: COMPLETED ·Phase: PHASE1
-
Tissue Study of Bv8/PK-2 Inhibition in Human Cancer
NCT01656824 ·Status: UNKNOWN
-
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
NCT00101309 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
NCT01697514 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
NCT00978146 ·Status: WITHDRAWN ·Phase: PHASE2